| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |